EP Patent

EP2671883A1 — New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands

Assigned to Bioprojet SC · Expires 2013-12-11 · 12y expired

What this patent protects

The present patent application concerns new ligands of the H4-receptor, their process of preparation and their therapeutic use.

USPTO Abstract

The present patent application concerns new ligands of the H4-receptor, their process of preparation and their therapeutic use.

Drugs covered by this patent

Patent Metadata

Patent number
EP2671883A1
Jurisdiction
EP
Classification
—
Expires
2013-12-11
Drug substance claim
No
Drug product claim
No
Assignee
Bioprojet SC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.